Mumbai, 02nd May 2025: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 90 mg and tentative approval for Ticagrelor Tablets, 60 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product […]
The post Alembic Pharma Secures USFDA Final Approval for Ticagrelor 90 mg, Tentative Nod for 60 mg first appeared on Business News Week.